Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marco Silingardi"'
Autor:
Chiara Chiavelli, Malvina Prapa, Giulia Rovesti, Marco Silingardi, Giovanni Neri, Giuseppe Pugliese, Lucia Trudu, Massimiliano Dall’Ora, Giulia Golinelli, Giulia Grisendi, Jonathan Vinet, Marco Bestagno, Carlotta Spano, Roberto Vito Papapietro, Roberta Depenni, Katia Di Emidio, Anna Pasetto, Daniela Nascimento Silva, Alberto Feletti, Silvia Berlucchi, Corrado Iaccarino, Giacomo Pavesi, Massimo Dominici
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-9 (2024)
Abstract Glioblastoma (GBM) remains a deadly tumor. Treatment with chemo-radiotherapy and corticosteroids is known to impair the functionality of lymphocytes, potentially compromising the development of autologous CAR T cell therapies. We here genera
Externí odkaz:
https://doaj.org/article/b35ac19b1e9c4db4933d30af0c9b01a2
Autor:
Rosanna Mezzapelle, Francesco De Marchis, Chiara Passera, Manuela Leo, Francesca Brambilla, Federica Colombo, Maura Casalgrandi, Alessandro Preti, Samuel Zambrano, Patrizia Castellani, Riccardo Ertassi, Marco Silingardi, Francesca Caprioglio, Veronica Basso, Renzo Boldorini, Angelo Carretta, Francesca Sanvito, Ottavio Rena, Anna Rubartelli, Lina Sabatino, Anna Mondino, Massimo P Crippa, Vittorio Colantuoni, Marco E Bianchi
Publikováno v:
EMBO Molecular Medicine, Vol 13, Iss 6, Pp n/a-n/a (2021)
Abstract Boosting antitumor immunity has emerged as a powerful strategy in cancer treatment. While releasing T‐cell brakes has received most attention, tumor recognition by T cells is a pre‐requisite. Radiotherapy and certain cytotoxic drugs indu
Externí odkaz:
https://doaj.org/article/7c8a2a6a178841389b768af27e2468c2
Autor:
Marco Bianchi, Francesca Sanvito, Rosanna Mezzapelle, Ottavio Rena, Lina Sabatino, Vittorio Colantuoni, Francesca Caprioglio, Federica Colombo, Patrizia Castellani, Maura Casalgrandi, Francesca Brambilla, Chiara Passera, Manuela Leo, Angelo Carretta, Veronica Basso, Anna Rubartelli, Francesco De Marchis, Massimo P. Crippa, Samuel Zambrano, Renzo Boldorini, Marco Silingardi, Anna Mondino, Alessandro Preti, Riccardo Ertassi
Publikováno v:
EMBO Molecular Medicine
EMBO Molecular Medicine, Vol 13, Iss 6, Pp n/a-n/a (2021)
EMBO Molecular Medicine, Vol 13, Iss 6, Pp n/a-n/a (2021)
Boosting antitumor immunity has emerged as a powerful strategy in cancer treatment. While releasing T‐cell brakes has received most attention, tumor recognition by T cells is a pre‐requisite. Radiotherapy and certain cytotoxic drugs induce the re